Inhibrx Biosciences Inc (INBX)
Operating Expenses
$126.13M
TTM · Period ending: · USD
INBX Operating Expenses
Latest reported$126.13Mperiod ending
Latest reported$126.13Mperiod ending
INBX TTM Operating Expenses ($4.40M → $126.13M)
TTM operating expenses
High-resolution chart · PNG
INBX operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 126,128,000 | |
| 122,006,000 | |
| 133,842,000 | |
| 152,822,000 | |
| 165,629,000 | |
| 298,600,000 | |
| 329,839,000 | |
| 370,125,000 | |
| 369,730,000 | |
| 249,806,000 | |
| 219,830,000 | |
| 165,259,000 | |
| 149,179,000 | |
| 142,705,000 | |
| 128,463,000 | |
| 114,977,000 | |
| 106,072,000 | |
| 92,227,000 | |
| 65,972,999 | |
| 64,287,999 | |
| 65,014,999 | |
| 64,760,999 | |
| 80,251,000 | |
| 77,089,000 | |
| 60,732,000 | |
| 41,862,999 | |
| 24,834,999 | |
| 9,770,999 | |
| 5,720,999 | |
| 4,972,000 | |
| 4,397,000 |